Addressing an Assocham event, Chairman of FSSAI Ashish Bahuguna said, “Everyone expects the acceptability of nutraceuticals to grow. I feel the first challenge is that consumers have confusion. There is so much misinformation.”
There are also false claims about the products. The consumers want claims on labels to be clear. The industry should clarify the difference between nutraceuticals and pharmceuticals, he said asking the industry to work in this direction.
Consumer interest and safety should be the priority for the industry, for which it should adopt self-regulation, he added.
Bahuguna further said, “FSSAI makes stringent rules that no one violates. Manufacturers have bigger responsibility to make quality and safe products.”
Nutraceuticals sector is growing fast and will grow faster in the coming years. FSSAI is open to accepting suggestions to improve the sector, he added.
Highlighting the challenges faced in the sector, Sami-Sabinsa Group founder and chairman Muhammed Majeed said the industry should be worried about herbal security as the country cannot depend on other nations like Indonesia for regular supply.
“In Ayurveda, if you don’t get one herb, it is adulterated with other. Even in nutraceuticals, it happens. Therefore, herbal security is important,” he said.
Majeed also said India should patent new products else other countries will do so, affecting the domestic industry.
Health Foods and Dietary Supplements Association (HADSA) President Ajit Singh said the domestic industry has many problems with regard to packaging and hygiene.
The nutraceuticals industry is forced to make products from equipments and processes designed by pharma industry. “We need to redesign equipments for nutraceuticals,” he said.
Another problem is that nutraceuticals are packed scientifically. They are packed in plastics that reduce the quality of dosages each time the bottle is opened, he said and suggested blister packaging.
According to an Assocham Knowledge report, the Indian nutraceuticals market is expected to grow from USD 4 billion in 2017 to $18 billion in 2025.